There is a story behind this article that I wrote about in a companion piece. A patient who had been on Synthroid for twenty years, managed by an endocrinologist, with a TSH that looked perfect at every annual visit. And more than ten active thyroid symptoms that had been attributed to everything except the one thing that was actually driving them. If you want to read that story first, it is here: Her Hairdresser Noticed Before Her Endocrinologist Did.
What follows is the clinical framework behind it. Why T4-only medication has significant limitations that standard monitoring cannot detect, what a complete thyroid panel actually measures, and why so many women on thyroid medication are still symptomatic and being told their thyroid is fine.
Key Highlights
- Synthroid and other T4-only medications normalize TSH but do not guarantee that T4 is being converted to active T3 at the cellular level
- TSH is a pituitary feedback signal, not a direct measure of thyroid function. On exogenous T4, TSH suppression tells you almost nothing about cellular thyroid status
- A complete thyroid panel reveals what TSH and T4 alone cannot show. It includes: TSH, free T3, total T3, free T4, total T4, reverse T3, T3 uptake, anti-TPO antibodies, and anti-thyroglobulin antibodies
- Poor T4 to T3 conversion is driven by upstream factors including gut dysfunction, liver stress, blood sugar dysregulation, chronic stress, and nutrient deficiency
- Women in perimenopause and menopause are particularly vulnerable to conversion impairment because the hormonal shift directly affects the systems driving conversion
- Desiccated thyroid and compounded T3/T4 combinations address the conversion problem in ways that T4-only medication cannot
What Synthroid Actually Does
Synthroid is levothyroxine, a synthetic form of T4. It is not biologically identical to the hormone your thyroid produces. It has been the standard pharmacological treatment for hypothyroidism since the 1960s and remains the most prescribed thyroid medication in the United States. It is effective at doing exactly what it is designed to do: provide the body with T4 and suppress TSH into the normal range.
The problem is that T4 is largely inactive. It is a storage and transport hormone. Before it can do anything useful at the cellular level, it has to be converted to T3, the active hormone that drives metabolic function in virtually every cell in the body. That conversion happens primarily in the liver, the gut, and peripheral tissues, and it depends on a cascade of enzymatic processes that are sensitive to stress, inflammation, nutrient status, and metabolic health.
When Synthroid normalizes TSH, it is telling you that the pituitary gland is satisfied with the level of T4 in circulation. It is not telling you whether that T4 is being converted to active T3. It is not telling you whether reverse T3 is occupying T3 receptors and blocking the hormone from doing its job. It is not telling you whether the gut, liver, or adrenals are impairing the conversion process. Those are different questions that require different tests.
Why TSH Is the Wrong Endpoint for Thyroid Management
TSH, thyroid stimulating hormone, is produced by the pituitary gland. It rises when the pituitary senses that thyroid output is insufficient and falls when output appears adequate. In a person who produces their own thyroid hormone, TSH is a reasonable proxy for thyroid status, though even then it has significant limitations.
In a person taking exogenous T4, TSH becomes even less informative. When you give someone Synthroid, you are adding T4 from outside. The pituitary senses T4 in circulation, concludes the system is satisfied, and suppresses TSH. A normalized TSH on Synthroid tells you that the medication is reaching the pituitary and quieting its signal. It tells you nothing about what is happening downstream, at the level of conversion and cellular uptake.
This is why women can be on Synthroid for years, with perfect TSH readings at every visit, while their free T3 is low, their reverse T3 is elevated, and their bodies are functionally hypothyroid at the cellular level. The number that gets managed is not the number that matters most. And the woman who is still exhausted, still losing hair, still gaining weight, still cold and foggy and achy, gets told her thyroid is fine, and her symptoms get attributed to aging, stress, or something else entirely.
The Complete Thyroid Panel: What Each Marker Reveals
A complete thyroid panel gives a full picture of what the thyroid is producing, how effectively it is being converted, whether something is blocking cellular uptake, and whether an autoimmune process is running underneath the whole picture. Here is what each marker adds.
TSH
Still worth tracking for context, but normalized TSH in someone on T4 medication is expected and does not confirm adequate thyroid function. The range considered optimal in functional medicine, typically between 1.0 and 2.0, is narrower than standard lab ranges, and even within that range TSH tells you more about the pituitary than it does about cellular thyroid status.
Free T4 and Total T4
Free T4 measures the unbound, circulating T4 available for conversion. Total T4 includes both bound and unbound. In someone on Synthroid, T4 levels are expected to be present. The clinical question is not whether T4 is there but whether it is being converted effectively. Adequate T4 with poor conversion is exactly the pattern that standard monitoring misses.
Free T3
Free T3 is the metabolically active hormone. It is what drives energy production, metabolic rate, cognitive function, hair growth, digestive motility, mood regulation, and cardiovascular function. Low free T3 in the presence of adequate T4 is the signature of a conversion problem. It is one of the most consistent findings in women who are symptomatic on T4-only medication, and it is almost never checked in standard thyroid management. The symptoms of low cellular T3 may include:
- Excessive fatigue
- Heaviness or body fatigue
- Depression
- Anxiety or panic attacks
- Irritability
- Poor memory
- Difficulty concentrating
- Hoarse voice
- Slow heart rate
- Heart palpitations
- Ringing in the ears
- Constipation
- Brittle nails
- Hair loss
- Painful periods
- PMS
- Joint pain
- Muscle pain
- Morning stiffness
- Easy bruising
- Fluid retention
- Low libido
- Poor circulation
- Cold hands and feet
- Headaches or migraines
- Insomnia
- Sleep apnea
- Dizziness or vertigo
- Excessive ear wax
- High cholesterol
- Weight gain
- Infertility
Many of these get attributed to aging, stress, or separate conditions and treated as unrelated problems when they share a single root cause.
Total T3
Total T3 includes both bound and free fractions. Read alongside free T3, it adds context about binding protein activity and helps complete the conversion picture. It can show whether the problem is in the conversion itself or in how much of the converted T3 is available to cells.
Reverse T3
When the body is under significant stress, inflammation, blood sugar dysregulation, or metabolic pressure, it converts T4 into reverse T3 rather than active T3. Reverse T3 is a structural mirror of T3 that occupies the same cellular receptors but does not activate them. It is a metabolic brake. An important distinction here: reverse T3 can fall within the standard clinical reference range and still be functionally too high. Standard labs flag values outside the reference range. Optimal medicine looks at where within that range a value sits and whether it is trending in the wrong direction relative to the rest of the panel. Elevated reverse T3, even when technically normal, is one of the most common and most overlooked explanations for why a woman on Synthroid still feels hypothyroid. More T4 does not fix this. It can make it worse by giving the body more substrate to convert into the inactive form.
T3 Uptake
T3 uptake reflects the activity of thyroxine-binding globulin, the protein that binds thyroid hormones in circulation. Low T3 uptake indicates elevated binding protein activity, meaning more T3 is bound and unavailable to cells. Like reverse T3, T3 uptake can sit within the standard reference range and still be suboptimal. A value at the low end of normal, read alongside a reverse T3 at the high end of normal, tells a clinically meaningful story even when neither number technically falls outside the flagged range. In women, low T3 uptake is most commonly driven by elevated estrogen and insulin surges, both of which raise TBG levels and reduce the amount of free thyroid hormone available to cells. This is particularly relevant in perimenopausal women who may be on oral estrogen or who have insulin resistance running in the background.
Anti-TPO and Anti-Thyroglobulin Antibodies
These are the autoimmune markers. Anti-TPO targets thyroid peroxidase, an enzyme essential to thyroid hormone synthesis. Anti-thyroglobulin targets the protein precursor from which thyroid hormones are built. Elevated antibodies indicate Hashimoto's thyroiditis, the most common cause of hypothyroidism in women, and they can be significantly elevated for years before TSH shifts out of range. Running only TSH and T4 misses autoimmune thyroid disease entirely in its early and mid stages. Treating T4 replacement without addressing the autoimmune process is like refilling a leaking tank without fixing the leak.
Why Perimenopause and Menopause Amplify the Problem
Women in perimenopause and menopause are particularly vulnerable to the kind of conversion impairment that T4-only medication cannot address. Several things happen during this transition that directly affect thyroid hormone conversion and cellular availability.
Estrogen decline changes the ratio of thyroid hormone binding proteins. As estrogen drops, TBG levels shift, altering how much free T4 and T3 are available. Women who felt adequate on a stable Synthroid dose for years can find their symptoms returning during perimenopause not because their dose has changed but because the hormonal context in which their medication operates has changed significantly.
Cortisol dysregulation, which is extremely common in perimenopausal women, directly impairs T4 to T3 conversion and increases reverse T3 production. A woman who has been managing on elevated cortisol for years may find her thyroid symptoms worsening as she moves through the hormonal transition, because the adrenal pressure that was already compromising her conversion is now compounded by declining estrogen and progesterone.
Gut changes during perimenopause also affect thyroid conversion. Approximately 20 percent of T4 to T3 conversion occurs in the gut, and the gut microbiome shifts significantly during the menopausal transition. Increased gut permeability and dysbiosis, common during this period, impair the enzymatic processes that convert T4 to active T3 and can trigger or worsen autoimmune thyroid activity through molecular mimicry.
Blood sugar dysregulation, which tends to increase during and after menopause due to insulin sensitivity changes, suppresses thyroid hormone conversion and elevates reverse T3. A woman who was borderline insulin resistant before menopause may find her thyroid symptoms dramatically worsening as her metabolic picture shifts, while her TSH remains unchanged and her endocrinologist keeps her on the same dose she has taken for years.
What Desiccated Thyroid Does Differently
Desiccated thyroid, derived from porcine thyroid glands, contains both T4 and T3 in a ratio that approximates human thyroid output. Unlike Synthroid, which provides T4 only and relies entirely on the body's conversion machinery, desiccated thyroid delivers active T3 directly. For women whose conversion is impaired, this is a significant clinical difference.
The T3 in desiccated thyroid bypasses the conversion step that is failing. Cells receive active hormone directly rather than waiting for a conversion process that is being blocked by elevated cortisol, gut dysfunction, or blood sugar dysregulation. The clinical response, when the switch is made in the right patient, is often rapid and substantial. Energy improves. Hair loss slows or reverses. Joint stiffness eases. Brain fog lifts. These are not placebo effects. They are what happens when cells that have been functionally hypothyroid finally receive the hormone they need.
This is not to say desiccated thyroid is appropriate for everyone with a conversion problem. The underlying drivers of poor conversion also need to be addressed. If blood sugar dysregulation is pushing T4 toward reverse T3, stabilizing blood sugar is part of the treatment. If gut dysfunction is impairing conversion, gut healing is part of the treatment. Changing the medication without addressing the upstream cause produces an improvement that may be incomplete or that may not last.
The Upstream Drivers of Thyroid Conversion Failure
Poor T4 to T3 conversion does not happen in isolation. It is almost always driven by one or more upstream factors that standard thyroid management never looks at. Identifying and addressing these is the difference between managing a number and resolving a problem.
Gut dysfunction. The gut is responsible for approximately 20 percent of T4 to T3 conversion. Dysbiosis, intestinal permeability, and chronic gut inflammation directly impair this process. Gut bacteria also produce deiodinase enzymes that participate in conversion. When the microbiome is compromised, conversion suffers. Additionally, a leaky gut increases systemic inflammation, which upregulates reverse T3 production and suppresses thyroid receptor sensitivity.
Liver stress. The liver is the primary site of T4 to T3 conversion, handling approximately 60 percent of the process. Liver congestion from toxic burden, alcohol, medication load, or fatty liver impairs deiodinase activity and slows conversion. Women with elevated liver enzymes, history of significant toxic exposure, or mold burden are at particular risk for conversion impairment driven by compromised liver function.
Blood sugar dysregulation. Insulin resistance and chronically elevated blood sugar suppress T4 to T3 conversion and elevate reverse T3. Advanced glycation end products formed in the presence of high blood sugar also impair thyroid receptor function at the cellular level. Normalizing blood sugar is often one of the most impactful interventions in improving thyroid hormone availability, independent of medication changes.
Chronic stress and cortisol elevation. Cortisol directly inhibits the deiodinase enzyme responsible for T4 to T3 conversion and increases the enzyme that converts T4 to reverse T3 instead. A woman under chronic stress is physiologically running a program that redirects available thyroid hormone away from active use. This pattern cannot be corrected by increasing T4 dose.
Nutrient deficiency. Selenium is the most critical nutrient for thyroid hormone conversion. It is required by all three deiodinase enzymes that regulate the T4 to T3 and T4 to reverse T3 conversion pathways. Zinc, iron, and vitamin D also participate in thyroid hormone production, conversion, and receptor function. Deficiencies in any of these, common in perimenopausal women, impair the entire thyroid axis in ways that no amount of T4 replacement will correct.
What This Means for You
If you are on Synthroid or another T4-only medication and still feel symptomatic, the most likely explanation is not that you need a higher dose. It is that the conversion process is impaired and the medication you are taking cannot address that. The answer starts with a complete panel that shows the full picture, followed by identifying and treating the upstream drivers of whatever the panel reveals.
Managing TSH in isolation is not thyroid care. It is pituitary care. The two are related but they are not the same thing, and for the women who are most symptomatic, the difference between them is everything.
If you are in Menlo Park, Palo Alto, Atherton, Los Altos, Woodside, Portola Valley, or Redwood City and you have been told your thyroid is fine while living with symptoms that say otherwise, there are two ways to start.
If you want to talk through your symptoms first, schedule a Discovery Call.
If you are ready to get started, book the Discovery Experience.
Frequently Asked Questions
Is it safe to switch from Synthroid to desiccated thyroid?
For most people, yes, when done correctly with appropriate monitoring. The transition requires careful dose equivalency calculation and follow-up testing to confirm the new medication is producing the intended result. It is not a switch to make without clinical oversight, but it is a well-established and widely used approach that has been practiced in naturopathic and integrative medicine for decades.
Why do so many endocrinologists still rely only on TSH?
TSH became the gold standard for thyroid monitoring based on studies showing its correlation with thyroid hormone levels in untreated patients. In treated patients on T4, that correlation breaks down significantly, but the monitoring standard has been slow to change. The professional societies that set thyroid treatment guidelines have been cautious about expanding beyond TSH and T4, partly due to concerns about overtreatment and partly due to limited large-scale evidence on outcomes with more comprehensive monitoring. This does not mean the approach is correct. It means the system has not caught up with what clinical experience and a growing body of research are showing.
How long does it take to see improvement after switching to desiccated thyroid?
Some patients notice changes within weeks. Others take two to three months to stabilize on the new medication and see the full clinical response. Hair changes in particular take longer because the hair growth cycle is slow. What my patient noticed within a month, new growth and improved texture, was a relatively fast response. The full picture typically takes three to six months to assess properly.
Do I need to address the upstream drivers even if I switch medication?
Yes, in most cases. Changing to desiccated thyroid helps bypass a conversion problem but does not fix what is causing it. If gut dysfunction, blood sugar dysregulation, or chronic stress is driving reverse T3 elevation, those need to be addressed as part of the complete treatment plan. The medication change and the root cause work happen in parallel, not sequentially.
Can I get a complete thyroid panel through my regular doctor?
Some physicians will order a more comprehensive panel on request. Others will not order reverse T3 or T3 uptake as they are not considered standard of care. A naturopathic physician or functional medicine practitioner can order the full panel. This is part of what I assess in every thyroid workup at Wellness Architecture.
Is Hashimoto's thyroiditis relevant if I am already on thyroid medication?
Very much so. Hashimoto's is an autoimmune condition, not just a thyroid condition. Replacing thyroid hormone does not stop the immune attack on thyroid tissue. Women with unidentified Hashimoto's who are being managed on T4 replacement may continue to lose thyroid tissue, experience episodic hyper and hypothyroid swings as damaged tissue releases stored hormone, and carry the full inflammatory burden of an unaddressed autoimmune condition. Identifying and treating the autoimmune component requires antibody testing and a completely different clinical approach than dose management alone.
Related reading:
- Your Thyroid Is Not Fine Just Because Your TSH Is Normal
- The Complete Thyroid Panel Every Woman Over 45 Deserves and Almost Never Gets
- Why Hormone Replacement Alone Is Not Enough
- Why Stress Hits Women Over 45 Completely Differently
For further reference on thyroid hormone management and treatment guidelines, the American Thyroid Association provides patient-facing resources on hypothyroidism and thyroid medication.